Subject: You're invited to Europe's first CAR-T Congress
Following the ground-breaking developments in cell therapy, you're invited to Europe's first Combined CAR-T Congress.
VISIT WEBSITE
Join experts from pharma, biotech and academia in Berlin on 30th-31st January 2018 to explore the future of CAR-T therapy, and address the hurdles facing the industry.
  • Advancements in CAR-T manufacturing and automation
  • Improving the safety of CAR-T through safety switches
  • Exploring the role of the tumour microenvironment
  • Alternative CARs: The potential of CAR-Tregs & CAR-NK in immune regulation
  • A collaborative approach to drug development
DOWNLOAD AGENDA
18+ INDUSTRY LEADERS INCLUDING:
  • David Sourdive, Executive Vice President Technical Operations, Cellectis
  • Professor Hinrich Abken, Professor of Cancer Genetics, University Hospital of Cologne
  • Michaela Sharpe PhD, Head of Non-Clinical Safety and Immunotherapy Strategy, Cell & Gene Therapy Catapult
VIEW SPEAKERS

    This is an online snapshot of a newsletter created by the owner of BioInformant Worldwide, LLC | Stem Cell Industry Data (BioInformant.com, BIOINFORMANT | 800 Corporate Drive, Suite 301, 22554 Stafford) and sent via GetResponse on 2017-11-23. Report abuse